123 related articles for article (PubMed ID: 12553016)
1. Expression and role of thrombospondin-1 in colorectal cancer.
Miyanaga K; Kato Y; Nakamura T; Matsumura M; Amaya H; Horiuchi T; Chiba Y; Tanaka K
Anticancer Res; 2002; 22(6C):3941-8. PubMed ID: 12553016
[TBL] [Abstract][Full Text] [Related]
2. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
[TBL] [Abstract][Full Text] [Related]
3. Increased TGF-beta 1 protein expression in patients with advanced colorectal cancer.
Langenskiöld M; Holmdahl L; Falk P; Angenete E; Ivarsson ML
J Surg Oncol; 2008 Apr; 97(5):409-15. PubMed ID: 18176914
[TBL] [Abstract][Full Text] [Related]
4. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
7. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
[TBL] [Abstract][Full Text] [Related]
8. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
Nozawa T; Enomoto T; Koshida Y; Sato Y; Kuranami M
Dis Colon Rectum; 2004 Dec; 47(12):2093-100. PubMed ID: 15657660
[TBL] [Abstract][Full Text] [Related]
9. Decreased levels of precursor transforming growth factor beta1 in human colorectal cancer.
Dimberg J; Hugander A; Sirsjo A
Int J Mol Med; 2001 Jun; 7(6):597-601. PubMed ID: 11351271
[TBL] [Abstract][Full Text] [Related]
10. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
11. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
12. Soluble transforming growth factor beta type II receptor attenuates TGF-beta1 activity in human colorectal cancer LoVo cells.
Zhou R; Xiong B; Song H; Liu S; Wang X
Oncol Rep; 2008 Dec; 20(6):1449-56. PubMed ID: 19020727
[TBL] [Abstract][Full Text] [Related]
13. Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas.
Oshiba G; Kijima H; Himeno S; Kenmochi T; Kise Y; Tanaka H; Nishi T; Chino O; Shimada H; Machimura T; Tsuchida T; Nakamura M; Ueyama Y; Tanaka M; Tajima T; Makuuchi H
Anticancer Res; 1999; 19(5C):4375-8. PubMed ID: 10650779
[TBL] [Abstract][Full Text] [Related]
14. Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis.
Sutton CD; O'Byrne K; Goddard JC; Marshall LJ; Jones L; Garcea G; Dennison AR; Poston G; Lloyd DM; Berry DP
Clin Cancer Res; 2005 Sep; 11(18):6567-73. PubMed ID: 16166434
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.
Tuxhorn JA; McAlhany SJ; Yang F; Dang TD; Rowley DR
Cancer Res; 2002 Nov; 62(21):6021-5. PubMed ID: 12414622
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
18. [Expression of transforming growth factor beta 1 (TGF beta 1) and angiogenesis in broncho-pulmonary carcinoids].
Słodkowska J; Hasleton P; Radomski P
Pneumonol Alergol Pol; 2000; 68(7-8):319-26. PubMed ID: 11200746
[TBL] [Abstract][Full Text] [Related]
19. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.
Pohlers D; Beyer A; Koczan D; Wilhelm T; Thiesen HJ; Kinne RW
Arthritis Res Ther; 2007; 9(3):R59. PubMed ID: 17594488
[TBL] [Abstract][Full Text] [Related]
20. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]